... intervention for cases of severe bowed legs. In 2018, the United States Food and Drug Administration (FDA ...
... April 2018, the United States FDA approved burosumab (Crysvita , Ultragenyx, Novato, CA, USA), which is ...
... -related AEs: Not reported Insogna, 2018 (NCT02526160) [12] Design Phase 3, O, SA, SC, 48 wks Population ...
... , hypersensitivity Most common drug-related AE (20%): injection site erythema and extremity pain Carpenter, 2018 ...
... . Pharmaceutical Approval Update. Pharm. Ther. 2018, 43, 326327. Insogna, K.L.; Briot, K.; Imel, E.A.; Kamenicky, P ...